Clincosm LogoSign in Get a demo

Framing of Numerical Information in Cochrane Summaries

Sponsor
University of Split, School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT03442387
Collaborator
(none)
91
Enrollment
1
Location
2
Arms

Study Details

Study Description

Brief Summary

The aim of the study was to conduct three different parallel randomized controlled trials to assess how the different framing of Cochrane summary information (positive vs negative framing of health information) affects affect the perception of the efficacy and intention for use of the described treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Frame of numerical information
 N/A

Detailed Description

The aim of the study was to conduct three different parallel randomized controlled trials to assess how the different framing of Cochrane summary information (positive vs negative framing of health information) affects affect the perception of the efficacy and intention for use of the described treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
91 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Framing of Numerical Information in Cochrane Summaries: a Randomized Controlled Trial
Actual Study Start Date :
Jan 29, 2018
Actual Primary Completion Date :
Jan 29, 2018
Actual Study Completion Date :
Jan 29, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Positive frame

The numerical expressions were presented in a positive way: e.g. treatment was successful for 4 out of 10 persons.

Other: Frame of numerical information
Each group received only one frame of information.
Experimental: Negative frame

The numerical expressions were presented in a negative way: e.g. treatment was unsuccessful for 6 out of 10 persons.

Other: Frame of numerical information
Each group received only one frame of information.

Outcome Measures

Primary Outcome Measures

  1. Perception of effectiveness [Immediately after reading]

    One item on Likert type scale from 1-10, higher score indicates the higher perceived effectiveness.

Secondary Outcome Measures

  1. Desire to use the described treatment [Immediately after reading]

    One item on Likert type scale from 1-10, higher score indicates the greater desire to use the described treatment.

  2. Desire that treatment is prescribed by family doctor [Immediately after reading]

    One item on Likert type scale from 1-10. Higher score indicates the greater desire that treatment is prescribed by family doctor.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • First year medical students
Exclusion Criteria:
  • Those who have failed first year and have to repeat it.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Split School of Medicine Split Croatia 21000

Sponsors and Collaborators

  • University of Split, School of Medicine

Investigators

  • Principal Investigator: Ivan Buljan, MPsy, University of Split, School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ivan Buljan, Research Assistant, University of Split, School of Medicine
ClinicalTrials.gov Identifier:
NCT03442387
Other Study ID Numbers:
  • Grant No. IP-2014-09-7672
First Posted:
Feb 22, 2018
Last Update Posted:
Feb 26, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 26, 2018